BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23689643)

  • 21. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
    Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.
    Lee TS; Lee JY; Kim JW; Oh S; Seong SJ; Lee JM; Kim TJ; Cho CH; Kim SM; Park CY
    Gynecol Oncol; 2013 Nov; 131(2):289-93. PubMed ID: 23994534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
    Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
    Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gynecologic malignancies.
    Whitcomb BP
    Surg Clin North Am; 2008 Apr; 88(2):301-17, vi. PubMed ID: 18381115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
    Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gynecologic cancer outcomes in the elderly poor: A population-based study.
    Doll KM; Meng K; Basch EM; Gehrig PA; Brewster WR; Meyer AM
    Cancer; 2015 Oct; 121(20):3591-9. PubMed ID: 26230631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
    Zivanovic O; Khoury-Collado F; Abu-Rustum NR; Gemignani ML
    Oncologist; 2009 Jul; 14(7):695-705. PubMed ID: 19608640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation therapy for gynecologic malignancies.
    Bradley KA; Petereit DG
    Hematol Oncol Clin North Am; 2006 Apr; 20(2):347-61. PubMed ID: 16730298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gynecologic cancer in the elderly.
    Termrungruanglert W; Kudelka AP; Edwards CL; Delclos L; Verschraegen CF; Kavanagh JJ
    Clin Geriatr Med; 1997 May; 13(2):363-79. PubMed ID: 9115456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.
    Perri T; Korach J; Ben-Baruch G; Jakobson-Setton A; Ben-David Hogen L; Kalfon S; Beiner M; Helpman L; Rosin D
    Eur J Surg Oncol; 2014 Jul; 40(7):899-904. PubMed ID: 24268761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian, uterine, and cervical cancer in the elderly woman.
    McGonigle KF; Lagasse LD; Karlan BY
    Clin Geriatr Med; 1993 Feb; 9(1):115-30. PubMed ID: 8443730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.
    Yamagami W; Aoki D
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1861-9. PubMed ID: 26420746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.
    Divine LM; Kizer NT; Hagemann AR; Pittman ME; Chen L; Powell MA; Mutch DG; Rader JS; Thaker PH
    Gynecol Oncol; 2016 Jul; 142(1):76-82. PubMed ID: 27117923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
    Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer in elderly patients: a difference in treatment based on age?
    Giuliani J; Drudi F
    Arch Gynecol Obstet; 2012 Dec; 286(6):1545-8. PubMed ID: 22843035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.